Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Fraenkel, Liana; Bathon, Joan; England, Bryant; St Clair, William; Arayssi, Thurayya; Carandang, Kristine; Deane, Kevin; Genovese, Mark; Huston, Kent; Kerr, Gail; Akl, Elie; Turner, Amy.
    Arthritis care res; 73 (7), 2021
    To develop updated guidelines for the pharmacologic management of rheumatoid arthritis. We developed clinically relevant population, intervention, comparator, and outcomes (PICO) questions. After conducting a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluat...
    Artritis Reumatoide/tratamiento farmacológico, Artritis Reumatoide/diagnóstico, Antirreumáticos/uso terapéutico, Glucocorticoides/uso terapéutico, Metotrexato/uso terapéutico
    Texto completo

    Psoriasis: assessment and management

    England. National Institute for Health and Care Excellence.
    This guideline covers assessing and managing psoriasis in adults, young people and children. It aims to improve long-term disease control and quality of life for people with psoriasis. NICE has produced a COVID-19 rapid guideline on dermatological conditions treated with drugs affecting the immune resp...
    Psoriasis/diagnóstico, Psoriasis/terapia, Terapia PUVA/normas, Psoriasis/tratamiento farmacológico, Ciclosporina/uso terapéutico, Metotrexato/uso terapéutico, Acitretina/uso terapéutico
    Texto completo

    American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease

    Terdiman, JP; Gruss, CB; Heidelbaugh, JJ; Sultan, S; Falck-Ytter, YT.
    Gastroenterology; 145 (6), 2013
    Factor de Necrosis Tumoral alfa, Mercaptopurina, Azatioprina, Metotrexato, Enfermedad de Crohn, Gastroenterología, Mercaptopurina/uso terapéutico, Metotrexato/uso terapéutico, Inducción de Remisión, Enfermedad de Crohn/tratamiento farmacológico, Factor de Necrosis Tumoral alfa/antagonistas & inhibidores
    Texto completo